An imbalance between CD36 and ABCA1 protein expression favors lipid accumulation in stroke-prone ulcerated carotid
Pia M Isoviita1, Krista Nuotio, Jani Saksi
1Research Program of Molecular Neurology, Biomedicum Helsinki, Helsinki, Finland. pia.isoviita@helsinki.fi
Insights
An imbalance of CD36 and ABCA1 in carotid plaques (CP) promotes lipid accumulation and instability. CD36
Area of Science:
- Cardiovascular Biology
- Atherosclerosis Research
- Macrophage Biology
Background:
- CD36 facilitates modified lipoprotein uptake; ABCA1 promotes lipid efflux.
- Previous microarray data indicated CD36 and ABCA1 gene overexpression in symptomatic carotid plaques (CP).
- This study investigates the roles of CD36 and ABCA1 in CP destabilization.
Purpose of the Study:
- To evaluate the role of CD36 and ABCA1 in carotid plaque destabilization.
- To examine the localization of lipids, CD36, ABCA1, extravasated red blood cells, and necrotic tissue in CP.
Main Methods:
- Analysis of 92 high-grade stenosing carotid endarterectomy specimens.
- Oil-red-O staining for neutral lipids.
- Immunohistochemical analysis of CD36 and ABCA1 in symptomatic and nonsymptomatic CP.
Main Results:
- Symptomatic CP showed increased extracellular lipid and CD36 expression compared to nonsymptomatic CP.
- CD36 expression was higher than ABCA1 in ulcerated CP, with the reverse in nonulcerated CP.
- CD36 colocalized with extravasated red blood cells and necrotic areas, suggesting a role in intraplaque hemorrhage.
Conclusions:
- An imbalance favoring CD36 (lipid influx) over ABCA1 (lipid efflux) contributes to macrophage lipid accumulation and ulcerated CP destabilization.
- CD36's colocalization with red blood cells indicates intraplaque hemorrhage may increase lipid load and affect CP stability.
Background:
CD36 is a macrophage scavenger receptor mediating the uptake of modified lipoproteins, whereas the ABCA1 transporter counteracts this effect by mediating cellular lipid efflux. Based on a DNA microarray, we previously found that the CD36 and ABCA1 genes were overexpressed in symptom-causing carotid plaques (CP) compared with nonsymptom-causing CP. To evaluate their role in CP destabilization, we conducted detailed immunohistochemical studies on the localization of lipids, CD36 and ABCA1 proteins, extravasated red blood cells, and atheromatous/necrotic tissue.
Methods:
Ninety-two high-grade (>70%) stenosing CP obtained from carotid endarterectomy were Oil-red-O-stained for evaluation of neutral lipids. Subgroups of nonsymptom-causing and symptom-causing CP (n=42) were further analyzed by immunostaining adjacent histological sections against CD36 and ABCA1 and examining them microscopically.
Results:
When compared with nonsymptom-causing CP, the amount of extracellular lipid and the expression of CD36 protein were elevated in symptom-causing CP, but no difference was found in ABCA1 expression. These observations were also confirmed when ulcerated and nonulcerated CP were compared. In ulcerated CP, CD36 protein expression was higher than that of ABCA1, and the opposite was true in nonulcerated CP. CD36 colocalized with extravasated red blood cells and atheromatous or necrotic areas in the various types of CP.
Conclusions:
Our results suggest that an imbalance between lipid influx (CD36) and efflux (ABCA1) favors lipid accumulation in macrophages of ulcerated CP, thus contributing to plaque destabilization. Furthermore, colocalization of CD36 protein with red blood cells suggests that intraplaque hemorrhages may contribute to the lipid load and thus the stability of CP.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Ischemic Stroke ll: Pathophysiology
